Mirum Pharmaceuticals Inc MIRM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:12 AM EDT
25.24quote price arrow up+0.12 (+0.48%)
Volume
36,088
52 week range
21.83 - 35.56
Loading...
  • Open25.66
  • Day High25.79
  • Day Low25.14
  • Prev Close25.12
  • 52 Week High35.56
  • 52 Week High Date12/15/23
  • 52 Week Low21.83
  • 52 Week Low Date03/30/23

Key Stats

  • Market Cap1.186B
  • Shares Out47.00M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-14.33

KEY STATS

  • Open25.66
  • Day High25.79
  • Day Low25.14
  • Prev Close25.12
  • 52 Week High35.56
  • 52 Week High Date12/15/23
  • 52 Week Low21.83
  • 52 Week Low Date03/30/23
  • Market Cap1.186B
  • Shares Out47.00M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-14.33

RATIOS/PROFITABILITY

  • EPS (TTM)-4.08
  • P/E (TTM)-6.18
  • Fwd P/E (NTM)-18.42
  • EBITDA (TTM)-98.325M
  • ROE (TTM)-83.65%
  • Revenue (TTM)186.374M
  • Gross Margin (TTM)74.76%
  • Net Margin (TTM)-87.68%
  • Debt To Equity (MRQ)123.22%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mirum Pharmaceuticals Inc

 

Profile

MORE
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development and commercialization of therapies for debilitating rare and orphan diseases. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the...
Michael Grey
Chairman of the Board
Christopher Peetz
Chief Executive Officer, Co-Founder, Director
Peter Radovich
President, Chief Operating Officer
Eric Bjerkholt
Principal Financial Officer
Address
950 Tower Ln Ste 1050
Foster City, CA
94404-4251
United States

Top Peers

SYMBOLLASTCHG%CHG
DCPH
Deciphera Pharmaceuticals Inc
15.39+0.21+1.38%
MNKD
MannKind Corp
4.51-0.12-2.48%
XNCR
Xencor Inc
21.87-0.55-2.45%
LGND
Ligand Pharmaceuticals Inc
71.47+0.20+0.28%
PACB
Pacific Biosciences of California Inc
3.71-0.01-0.27%